Investigation of the Effects of Frailty and Sarcopenia on Postoperative Recovery and Complications in Geriatric Patients
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Mar 17, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Frailty is a clinically identifiable state of heightened vulnerability resulting from age-related declines in physiological systems and functions, leading to impaired resilience to stressors. Frailty is highly prevalent among the elderly and is associated with an increased risk of falls, disability, hospitalization, and mortality. Magnetic resonance imaging (MRI) and computed tomography (CT) are considered the gold standard for sarcopenia diagnosisCT is also limited due to radiation exposure and similar logistical constraints. In contrast, ultrasonography (USG) is portable, cost-effective, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients over 60 years of age who are undergoing colorectal malignancy surgery under general anesthesia
- • patients willing to participate in the study
- • Patients with ASA score I-III
- Exclusion Criteria:
- • Patients with Parkinson's disease,
- • Alzheimer's disease,
- • history of cerebrovascular events,
- • neuromuscular disease,
- • cognitive dysfunction,
- • severe liver disease,
- • severe heart disease,
- • impaired cooperation due to kidney disease,
- • emergency and trauma patients,
- • patients with bilateral lower extremity amputations
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eski̇şehi̇r, Odunpazarı, Turkey
Patients applied
Trial Officials
ferda yaman, Assoc prof
Principal Investigator
University of Eskişehir Osmangazi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported